Licenses Granted for Three Probiotics
Three spore-forming probiotics with claims were granted product licenses by Health Canada to Specialty Enzymes & Probiotics.
Three spore-forming probiotics with claims have been granted product licenses by Health Canada, Specialty Enzymes & Probiotics is pleased to announce. The company has achieved product license for SEBiotic™ (Bacillus coagulans LBSC), SEBtilis™ (Bacillus subtilis PLSSC), and SEBclausii™ (Bacillus clausii 088AE).
The three Bacillus probiotic strains were created and researched in order to offer consumers a variety of health advantages. Health Canada has approved specific claims for each product; for more information, get in touch with the business.
“We are thrilled Health Canada has approved a natural health product license for these three probiotics,” said Vic Rathi, CEO & Founder of Specialty Enzymes & Probiotics. “We work tirelessly to develop products that are effective and marketable for our customers. This is a great milestone, and we are excited to offer these ingredients to the Canadian market.”
Probiotics that produce spores are renowned for their capacity to endure harsh conditions and maintain stability throughout the digestive process. This enables them to enter the intestines and colonize the gut, where they can offer a variety of health advantages, such as promoting reduced inflammation, nutrient absorption, and immune system support.
Specialty Enzymes & Probiotics is committed to providing high-quality, science-backed probiotic, enzymes and protein products to help support digestive health and overall wellness. With the approval of these three spore-forming probiotics, the company is poised to make a significant impact on the health and wellbeing of Canadians.
SOURCE Specialty Enzymes & Probiotics
Note: Content may be edited for style and length
